{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:46:55Z","timestamp":1784548015348,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jchromb.2021.122985","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T07:23:14Z","timestamp":1634023394000},"page":"122985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A new dried blood spot LC-MS\/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer"],"prefix":"10.1016","volume":"1185","author":[{"given":"Ariana Soledad","family":"Poetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Posocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-5780","authenticated-orcid":false,"given":"Marco","family":"Orleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zanchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Iacuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Canil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Buzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0377-8232","authenticated-orcid":false,"given":"Marcella","family":"Montico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-3502","authenticated-orcid":false,"given":"Michela","family":"Guardascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Pelizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gerratana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Toffoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jchromb.2021.122985_b0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc1629","article-title":"Pharmacokinetic variability of anticancer agents","volume":"5","author":"Undevia","year":"2005","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.jchromb.2021.122985_b0010","first-page":"100240","article-title":"Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance","volume":"25","author":"Ilan","year":"2020","journal-title":"Cancer Treat. Res. Commun."},{"issue":"12","key":"10.1016\/j.jchromb.2021.122985_b0015","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ejca.2014.04.015","article-title":"Review of therapeutic drug monitoring of anticancer drugs part two - Targeted therapies","volume":"50","author":"Widmer","year":"2014","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.jchromb.2021.122985_b0020","doi-asserted-by":"crossref","unstructured":"S. Capiau, J.W. Alffenaar, C.P. Stove, Alternative Sampling Strategies for Therapeutic Drug Monitoring, in: Clin. Challenges Ther. Drug Monit. Spec. Popul. Physiol. Cond. Pharmacogenomics, Elsevier Inc., 2016: pp. 279\u2013336. https:\/\/doi.org\/10.1016\/B978-0-12-802025-8.00013-1.","DOI":"10.1016\/B978-0-12-802025-8.00013-1"},{"key":"10.1016\/j.jchromb.2021.122985_b0025","unstructured":"EMEA ANNEX I - SUMMARY OF PRODUCT CHARACTERISTICS of Ibrance (palbociclib). https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ibrance-epar-product-information_en.pdf, April 2021."},{"key":"10.1016\/j.jchromb.2021.122985_b0030","unstructured":"EMEA ANNEX I - SUMMARY OF PRODUCT CHARACTERISTICS of Kisqali (ribociclib). https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kisqali-epar-product-information_en.pdf, April 2021."},{"key":"10.1016\/j.jchromb.2021.122985_b0035","unstructured":"NOVARTIS. Femara \u00ae (letrozole tablets). Metabolism Clinical And Experimental https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2001\/20726S006LBL.PDF."},{"issue":"12","key":"10.1016\/j.jchromb.2021.122985_b0040","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ejca.2014.04.014","article-title":"Review of therapeutic drug monitoring of anticancer drugs part 1 - Cytotoxics","volume":"50","author":"Paci","year":"2014","journal-title":"Eur. J. Cancer."},{"issue":"12","key":"10.1016\/j.jchromb.2021.122985_b0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s40262-020-00930-x","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib","volume":"59","author":"Groenland","year":"2020","journal-title":"Clin. Pharmacokinet."},{"issue":"15_suppl","key":"10.1016\/j.jchromb.2021.122985_b0050","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1200\/JCO.2018.36.15_suppl.2571","article-title":"Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) in routine practice in an oncology service. preliminary results","volume":"36","author":"Sureda","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jchromb.2021.122985_b0055","author":"Humber","year":"2007","journal-title":"Clinical Pharmacol. Rev."},{"key":"10.1016\/j.jchromb.2021.122985_b0060","unstructured":"C.J. George Chang & T. Palmby Multi-discipline review 209092Orig1s000. CENTER FOR DRUG EVALUATION AND RESEARCH (2017). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209092orig1s000multidiscipliner.pdf."},{"issue":"3","key":"10.1016\/j.jchromb.2021.122985_b0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40262-018-0683-0","article-title":"Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology","volume":"58","author":"Groenland","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122985_b0070","doi-asserted-by":"crossref","first-page":"e0228822","DOI":"10.1371\/journal.pone.0228822","article-title":"Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS\/MS method for clinical application","volume":"15","author":"Posocco","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jchromb.2021.122985_b0075","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research (CDER). Bioanalytical Method Validation Guidance for Industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry. Accessed 18th May 2021."},{"key":"10.1016\/j.jchromb.2021.122985_b0080","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf. Accessed 18th May 2021."},{"key":"10.1016\/j.jchromb.2021.122985_b0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"17","key":"10.1016\/j.jchromb.2021.122985_b0090","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4155\/bio.13.170","article-title":"The effect of hematocrit on bioanalysis of DBS: Results from the EBF DBS-microsampling consortium","volume":"5","author":"de Vries","year":"2013","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2021.122985_b0095","series-title":"Therapeutic Drug Monitoring Data","author":"Dasgupta","year":"2019"},{"issue":"5","key":"10.1016\/j.jchromb.2021.122985_b0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-021-03036-6","article-title":"Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations","volume":"38","author":"Iacuzzi","year":"2021","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122985_b0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/rcm.1777","article-title":"A novel liquid chromatography\/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery","volume":"19","author":"Yu","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2021.122985_b0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s13318-018-0469-7","article-title":"In Vivo Red Blood Cells\/Plasma Partition Coefficient of Treosulfan and Its Active Monoepoxide in Rats","volume":"43","author":"Roma\u0144ski","year":"2018","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2021.122985_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/FTD.0000000000000673","article-title":"Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children","volume":"42","author":"Dilo","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2021.122985_b0120","doi-asserted-by":"crossref","first-page":"114118","DOI":"10.1016\/j.jpba.2021.114118","article-title":"Quantification of ribociclib in dried blood spots by LC\u2013MS\/MS: Method development and clinical validation","volume":"201","author":"Braal","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122985_b0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dta.1646","article-title":"Dried blood spots: Concepts, present status, and future perspectives in bioanalysis","volume":"6","author":"Sharma","year":"2014","journal-title":"Drug Test. Anal."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221004669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221004669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:06:32Z","timestamp":1761606392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221004669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"alternative-id":["S1570023221004669"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122985","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new dried blood spot LC-MS\/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122985"}}